410 related articles for article (PubMed ID: 14685782)
1. Natural killer lymphocytes: biology, development, and function.
Papamichail M; Perez SA; Gritzapis AD; Baxevanis CN
Cancer Immunol Immunother; 2004 Mar; 53(3):176-86. PubMed ID: 14685782
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
3. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
[TBL] [Abstract][Full Text] [Related]
5. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
6. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
8. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
9. Interplay of natural killer cells and their receptors with the adaptive immune response.
Raulet DH
Nat Immunol; 2004 Oct; 5(10):996-1002. PubMed ID: 15454923
[TBL] [Abstract][Full Text] [Related]
10. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity.
Lauzon NM; Mian F; MacKenzie R; Ashkar AA
Cell Immunol; 2006 Jun; 241(2):102-12. PubMed ID: 17049504
[TBL] [Abstract][Full Text] [Related]
11. NK cell receptors as tools in cancer immunotherapy.
Sentman CL; Barber MA; Barber A; Zhang T
Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
[TBL] [Abstract][Full Text] [Related]
12. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
[TBL] [Abstract][Full Text] [Related]
13. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
[TBL] [Abstract][Full Text] [Related]
14. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
15. NK and NKT cell functions in immunosenescence.
Mocchegiani E; Malavolta M
Aging Cell; 2004 Aug; 3(4):177-84. PubMed ID: 15268751
[TBL] [Abstract][Full Text] [Related]
16. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell signaling pathways.
Vivier E; Nunès JA; Vély F
Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
[TBL] [Abstract][Full Text] [Related]
18. Activation of natural killer cells: underlying molecular mechanisms revealed.
Backström E; Kristensson K; Ljunggren HG
Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
[TBL] [Abstract][Full Text] [Related]
19. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
20. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B.
Albarran B; Goncalves L; Salmen S; Borges L; Fields H; Soyano A; Montes H; Berrueta L
APMIS; 2005; 113(7-8):526-35. PubMed ID: 16086823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
